Skip to main content

Advertisement

SpringerLink
Log in

Dexmedetomidine for sedation during epicardial ablation for ventricular tachycardia: a single-center experience

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

Epicardial approach to ventricular tachycardia (VT) ablation is mainly performed under general anesthesia (GA). Although catheter manipulation and ablation in the epicardial space could be painful, GA lowers blood pressure and may interfere with arrhythmia induction and mapping, and the use of muscle relaxants precludes identification of the phrenic nerve (PN). Moreover, an anesthesiologist’s presence is required during GA for the whole procedure, which may not always be possible. Therefore, we evaluated the feasibility and safety of epicardial VT ablations performed under conscious sedation using dexmedetomidine in our center.

Methods

Between January 2018 and January 2022, all patients who underwent epicardial VT ablation under continuous dexmedetomidine infusion were prospectively included in the study. All patients received premedication 30 min before the epicardial puncture with paracetamol (acetaminophen 10 mg/ml) 1000 mg and ketorolac 30 mg. Sedation protocol included an intravenous bolus of midazolam hydrochloride (0.03–0.05 mg/kg) followed by continuous infusion of dexmedetomidine (0.2–0.7 mcg/kg/h). In addition, an intravenous fentanyl citrate bolus (0.7–1.4 mcg/kg) was given for short-term analgesia, followed by a second dose repeated after 30 to 45 min. Sedation-related complications were defined in case of respiratory failure, severe hypotension, and bradycardia requiring treatment.

Results

Sixty-nine patients underwent epicardial or endo-epi VT ablation under conscious sedation and were included in the analysis. The mean age was 65.4 ± 12.1 years; forty-six patients were males (66.6%). All patients had drug-refractory recurrent VT. Forty-seven patients (68.1%) had non-ischemic cardiomyopathy (NICM), 13 patients (18.9%) had ischemic-cardiomyopathy (ICM), and 9 patients (13%) had myocarditis. Standard percutaneous sub-xiphoid access was attempted in all patients. Non-inducibility of any VT was achieved in 82.6% (9/9 myocarditis, 10/13 ICM, 38/47 NICM, n = 57/69 patients), inducibility of non-clinical VT in 13% (3/13 ICM, 6/38 NICM, n = 9/69 patients), and failure in 4.3% (3/38 NICM, n = 3/69 patients). Although we observed procedural-related complications in five patients (7.2%), one transient PN palsy, two pericarditis, and two vascular complications, those were not related to the conscious sedation protocol. No respiratory failure, severe hypotension, or bradycardia requiring treatment has been observed among the patients.

Conclusions

Prompt availability of anesthesiology support remains crucial for complex procedures such as epicardial VT ablation. Continuous infusion of dexmedetomidine and administration of midazolam and fentanyl seem to be a safe and effective sedation protocol in patients undergoing epicardial VT ablation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sacher F, Tedrow UB, Field ME, Raymond JM, Koplan BA, Epstein LM, Stevenson WG. Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol. 2008;1:153–61.

    Article  PubMed  Google Scholar 

  2. Sosa E, Scanavacca M, D’Avila A, Piccioni J, Sanchez O, Velarde JL, Silva M, Reolão B. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia. J Cardiovasc Electrophysiol. 1998;9(3):229–39.

    Article  CAS  PubMed  Google Scholar 

  3. Schweikert RA, Saliba WI, Tomassoni G, Marrouche NF, Cole CR, Dresing TJ, Tchou PJ, Bash D, Beheiry S, Lam C, Kanagaratnam L, Natale A. Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations. Circulation. 2003;108(11):1329–35.

    Article  PubMed  Google Scholar 

  4. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004;43(10):1834–42.

    Article  PubMed  Google Scholar 

  5. Tedrow U, Stevenson GW. Strategies for epicardial mapping and ablation of ventricular tachycardia. J Cardiovasc Electrophysiol. 2009;6:710–3.

    Article  Google Scholar 

  6. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59:2632–70.

    Article  Google Scholar 

  7. Castillo RL, et al. Dexmedetomidine improves cardiovascular and ventilatory outcomes in critically ill patients: basic and clinical approaches. Front Pharmacol. 2019;10:1641.

    Article  CAS  PubMed  Google Scholar 

  8. Keating GM. Dexmedetomidine: a review of its use for sedation in the intensive care setting. Drugs. 2015;75:1119–30.

    Article  CAS  PubMed  Google Scholar 

  9. Alexopoulou C, Kondili E, Diamantaki E, et al. Effects of dexmedetomidine on sleep quality in critically ill patients: a pilot study. Anesthesiology. 2014;121:801–7.

    Article  CAS  PubMed  Google Scholar 

  10. Lin YY, He B, Chen J, Wang ZN. Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? A meta-analysis. Crit Care. 2012;16:R169.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ji F, Li Z, Nguyen H, Young N, Shi P, Fleming N, Liu H. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013;127:1576–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Tobias JD, Chrysostomou C. Dexmedetomidine: antiarrhythmic effects in the pediatric cardiac patient. Pediatr Cardiol. 2013;34:779–85.

    Article  PubMed  Google Scholar 

  13. Dere K, Sucullu I, Budak ET, Yeyen S, Filiz AI, Ozkan S, Dagli G. A comparison of dexmedetomidine versus midazolam for sedation, pain and hemodynamic control, during colonoscopy under conscious sedation. Eur J Anaesthesiol. 2010;27:648–52.

    Article  CAS  PubMed  Google Scholar 

  14. Koruk S, Mizrak A, Gul R, Kilic E, Yendi F, Oner U. Dexmedetomidine-ketamine and midazolam-ketamine combinations for sedation in pediatric patients undergoing extracorporeal shock wave lithotripsy: a randomized prospective study. J Anesth. 2010;24:858–63.

    Article  PubMed  Google Scholar 

  15. McCutcheon CA, Orme RM, Scott DA, Davies MJ, McGlade DP. A comparison of dexmedetomidine versus conventional therapy for sedation and hemodynamic control during carotid endarterectomy performed under regional anesthesia. Anesth Analg. 2006;102:668–75.

    Article  CAS  PubMed  Google Scholar 

  16. Tosun Z, Akin A, Guler G, Esmaoglu A, Boyaci A. Dexmedetomidine-ketamine and propofol-ketamine combinations for anesthesia in spontaneously breathing pediatric patients undergoing cardiac catheterization. J Cardiothorac Vasc Anesth. 2006;20:515–9.

    Article  CAS  PubMed  Google Scholar 

  17. Mandel JE, Hutchinson MD, Marchlinski FE. Remifentanil-midazolam sedation provides hemodynamic stability and comfort during epicardial ablation of ventricular tachycardia. J Cardiovasc Electrophysiol. 2011;22:464–6.

    Article  PubMed  Google Scholar 

  18. Ramoul K, Tafer N, Sacher F, Shah AJ, Derval N, Remi J, Denis A, De Guillebon M, Bordachar P, Ritter P, Hocini M, Clementy J, Ouattara A, Haissaguerre M, Jais P, Knecht S. Conscious sedation with sufentanil and midazolam for epicardial VT ablation. J Innov Card Rhythm Manag. 2012;3:849–53.

    Google Scholar 

  19. Cho JS, Shin JK, Na S, Park I, Kwak YL. Improved sedation with dexmedetomidine-remifentanil compared with midazolam-remifentanil during catheter ablation of atrial fibrillation: a randomized, controlled trial. Europace. 2014;16:1000–6.

    Article  PubMed  Google Scholar 

  20. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. BMJ. 1974;2:656–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sosa E, Scanavacca M, d’Avila A, Pilleggi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996;7:531–6.

    Article  CAS  PubMed  Google Scholar 

  22. Brugada J, Berruezo A, Cuesta A, Osca J, Chueca E, Fosch X, Wayar L, Mont L. Nonsurgical transthoracic epicardial radiofrequency ablation: an alternative in incessant ventricular tachycardia. J Am Coll Cardiol. 2003;41:2036–43.

    Article  PubMed  Google Scholar 

  23. Sosa E, Scanavacca M. Epicardial mapping and ablation techniques to control ventricular tachycardia. J Cardiovasc Electrophysiol. 2005;16:449–52.

    Article  PubMed  Google Scholar 

  24. Gallagher JD. Electrophysiological mechanisms for ventricular arrhythmias in patients with myocardial ischemia: anesthesiologic considerations Pt II. J Cardiothorac Vasc Anesth. 1997;11:641–56.

    Article  CAS  PubMed  Google Scholar 

  25. Burjorjee JE, Milne B. Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol. Can J Anesth. 2002;49:973–7.

    Article  PubMed  Google Scholar 

  26. Mulpuru SK, Patel DV, Wilbur SL, Vasavada BC, Furqan T. Electrical storm and termination with propofol therapy: a case report. Int J Cardiol. 2008;128:e6–8.

    Article  PubMed  Google Scholar 

  27. Santangeli P, Muser D, Zado ES, Magnani S, Khetpal S, Hutchinson MD, Supple G, Frankle DS, Garcia FC, Bala R, Riley MP, Lin D, Rame JE, Schaller Dixit S, Marchlinski FE, Callans DJ. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8:68–75.

    Article  PubMed  Google Scholar 

  28. Bekker AY, Basile J, Gold M, Riles T, Adelman M, Cuff G, Mathew JP, Goldberg JD. Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol. 2004;16:126–35.

    Article  PubMed  Google Scholar 

  29. Talke P, Li J, Jain U, Leung J, Drasner K, Hollenberg M, Mangano DT. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. The Study of Perioperative Ischemia Research Group. Anesthesiology. 1995;82:620–33.

    Article  CAS  PubMed  Google Scholar 

  30. Fan R, Cano O, Ho SY, Bala R, Callans DJ, Dixit S, Garcia F, Gerstenfeld EP, Hutchinson M, Lin D, Riley M, Marchlinski FE. Characterization of the phrenic nerve course within the epicardial substrate of patients with non-ischemic cardiomyopathy and ventricular tachycardia. Heart Rhythm. 2009;6:59–64.

    Article  PubMed  Google Scholar 

  31. Okubo K, Trevisi N, Foppoli L, Bisceglia C, Baratto F, Gigli L, D’Angelo G, Radinovic A, Cireddu M, Paglino G, Mazzone P, Della BP. Phrenic nerve limitation during epicardial catheter ablation of ventricular tachycardia. JACC Clin Electrophysiol. 2019;5(1):81–90.

    Article  PubMed  Google Scholar 

  32. Killu AM, Sugrue A, Munger TM, Hodge DO, Mulpuru SK, McLeod CJ, Packer DL, Asirvatham SJ, Friedman PA. Impact of sedation vs. general anesthesia on percutaneous epicardial access safety and procedural outcomes. Europace. 2018;20:329–36.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Electrophysiology Unit, ARNAS Civico – Di Cristina – Benfratelli, P.Zza Nicola Leotta, 4, 90127, Palermo, Italy

    Sergio Conti, Francesco Sabatino, Antonio Cascino, Giuliano Ferrara & Giuseppe Sgarito

Authors
  1. Sergio Conti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Sabatino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Cascino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuliano Ferrara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giuseppe Sgarito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sergio Conti.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Institutional Review Board and all patients signed informed consent.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (MOV 40769 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Conti, S., Sabatino, F., Cascino, A. et al. Dexmedetomidine for sedation during epicardial ablation for ventricular tachycardia: a single-center experience. J Interv Card Electrophysiol 66, 79–85 (2023). https://doi.org/10.1007/s10840-022-01350-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-022-01350-6

Keywords

Search

Navigation